Stryker - 36 Year Stock Price History | SYK
- The all-time high Stryker stock closing price was 358.71 on March 27, 2024.
- The Stryker 52-week high stock price is 361.41, which is 0.8% above the current share price.
- The Stryker 52-week low stock price is 249.98, which is 30.3% below the current share price.
- The average Stryker stock price for the last 52 weeks is 297.62.
Stryker Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 335.3509 | 295.5708 | 358.7100 | 293.2859 | 358.7100 | 20.05% |
2023 | 277.9929 | 242.9037 | 302.7686 | 242.9037 | 298.7936 | 23.78% |
2022 | 227.7418 | 261.7211 | 270.8378 | 185.6678 | 241.3832 | -7.43% |
2021 | 248.6494 | 230.7550 | 271.7614 | 213.3678 | 260.7461 | 10.22% |
2020 | 192.0380 | 200.7173 | 236.5668 | 120.6497 | 236.5668 | 18.15% |
2019 | 188.1418 | 145.8311 | 210.4679 | 143.9056 | 200.2309 | 35.33% |
2018 | 156.3655 | 147.2944 | 168.2038 | 136.4059 | 147.9549 | 2.43% |
2017 | 129.5921 | 110.0470 | 148.5621 | 108.4990 | 144.4399 | 30.84% |
2016 | 101.1003 | 81.8276 | 112.4067 | 79.5642 | 110.3971 | 30.68% |
2015 | 86.1822 | 84.1656 | 94.2858 | 80.6553 | 84.4819 | 0.01% |
2014 | 73.7585 | 65.8505 | 86.2002 | 65.8505 | 84.4701 | 27.40% |
2013 | 59.3412 | 48.5194 | 66.3005 | 48.5194 | 66.3005 | 39.29% |
2012 | 46.1000 | 43.6232 | 48.8837 | 42.7369 | 47.5990 | 12.10% |
2011 | 46.3691 | 45.9749 | 54.8111 | 37.1167 | 42.4616 | -6.13% |
2010 | 43.5560 | 43.4173 | 49.1489 | 35.8923 | 45.2337 | 7.89% |
2009 | 34.5957 | 34.2161 | 43.3236 | 25.8340 | 41.9273 | 26.71% |
2008 | 49.6077 | 60.3478 | 60.5364 | 29.9115 | 33.0897 | -45.99% |
2007 | 54.5076 | 44.9982 | 62.4358 | 44.9982 | 61.2661 | 36.18% |
2006 | 38.6758 | 36.2658 | 45.2676 | 33.2409 | 44.9900 | 24.53% |
2005 | 39.2799 | 39.1387 | 45.5063 | 32.2843 | 36.1275 | -7.69% |
2004 | 38.1396 | 33.9078 | 46.4167 | 33.8025 | 39.1387 | 13.73% |
2003 | 29.1573 | 27.4902 | 34.4138 | 24.2893 | 34.4138 | 26.86% |
2002 | 23.2358 | 23.0872 | 27.1265 | 18.3310 | 27.1265 | 15.20% |
2001 | 21.7680 | 19.5719 | 24.7710 | 17.7637 | 23.5471 | 15.58% |
2000 | 16.3579 | 13.7469 | 21.7120 | 10.2529 | 20.3733 | 45.54% |
1999 | 11.5062 | 10.8358 | 14.3855 | 8.9797 | 13.9982 | 26.70% |
1998 | 8.1616 | 7.4569 | 11.0485 | 6.2939 | 11.0485 | 48.16% |
1997 | 6.9843 | 5.8802 | 8.9081 | 4.9261 | 7.4569 | 25.75% |
1996 | 5.1414 | 5.1892 | 6.2028 | 4.1518 | 5.9301 | 14.28% |
1995 | 4.3607 | 3.5945 | 5.6221 | 3.5945 | 5.1892 | 43.14% |
1994 | 3.1332 | 2.7661 | 3.6637 | 2.3609 | 3.6252 | 30.45% |
1993 | 2.6914 | 3.7751 | 3.7751 | 2.1573 | 2.7790 | -27.56% |
1992 | 3.5852 | 4.6500 | 5.0052 | 2.7172 | 3.8364 | -21.62% |
1991 | 2.6166 | 1.4665 | 5.0170 | 1.3807 | 4.8947 | 220.42% |
1990 | 1.2525 | 1.2097 | 1.5828 | 0.9412 | 1.5276 | 26.28% |
1989 | 0.9042 | 0.6436 | 1.2097 | 0.6436 | 1.2097 | 83.29% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $133.123B | $20.498B |
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $193.473B | 25.11 |
Medtronic (MDT) | Ireland | $111.139B | 15.73 |
EssilorLuxottica (ESLOY) | France | $102.775B | 0.00 |
Boston Scientific (BSX) | United States | $99.865B | 33.14 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.831B | 30.04 |
ResMed (RMD) | United States | $28.562B | 28.56 |
Terumo (TRUMY) | Japan | $27.589B | 38.84 |
Zimmer Biomet Holdings (ZBH) | United States | $26.224B | 16.91 |
Baxter (BAX) | United States | $21.095B | 15.39 |
Koninklijke Philips (PHG) | Netherlands | $18.610B | 14.84 |
Insulet (PODD) | United States | $11.574B | 60.85 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.401B | 0.00 |
Demant (WILYY) | Denmark | $11.148B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.711B | 28.93 |
BellRing Brands (BRBR) | United States | $7.779B | 41.82 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Haemonetics (HAE) | United States | $4.146B | 21.20 |
Lantheus Holdings (LNTH) | United States | $4.027B | 10.40 |
Prestige Consumer Healthcare (PBH) | United States | $3.575B | 16.90 |
Envista Holdings (NVST) | United States | $3.561B | 13.57 |
Neogen (NEOG) | United States | $3.248B | 31.25 |
QuidelOrtho (QDEL) | United States | $3.142B | 11.41 |
Green Thumb Industries (GTBIF) | United States | $2.981B | 94.47 |
ICU Medical (ICUI) | United States | $2.433B | 18.32 |
TG Therapeutics (TGTX) | United States | $2.384B | 772.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.097B | 0.00 |
Owens & Minor (OMI) | United States | $2.036B | 19.54 |
Verano Holdings (VRNOF) | United States | $1.879B | 0.00 |
InMode (INMD) | Israel | $1.736B | 8.99 |
National Vision Holdings (EYE) | United States | $1.710B | 53.24 |
Agios Pharmaceuticals (AGIO) | United States | $1.633B | 0.00 |
AdaptHealth (AHCO) | United States | $1.499B | 11.28 |
LeMaitre Vascular (LMAT) | United States | $1.470B | 48.81 |
AtriCure (ATRC) | United States | $1.407B | 0.00 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $0.888B | 0.00 |
Quanterix (QTRX) | United States | $0.834B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.820B | 0.00 |
Evolus (EOLS) | United States | $0.803B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.702B | 15.18 |
Canopy Growth (CGC) | Canada | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.543B | 0.00 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
PetIQ (PETQ) | United States | $0.524B | 19.55 |
TerrAscend (TSNDF) | Canada | $0.521B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.520B | 11.26 |
OraSure Technologies (OSUR) | United States | $0.465B | 7.70 |
Biote (BTMD) | United States | $0.440B | 4.18 |
ZimVie (ZIMV) | United States | $0.431B | 26.53 |
Surmodics (SRDX) | United States | $0.402B | 43.40 |
Zynex (ZYXI) | United States | $0.397B | 45.74 |
Viemed Healthcare (VMD) | United States | $0.352B | 34.96 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Cerus (CERS) | United States | $0.315B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 14.91 |
TriSalus Life Sciences (TLSI) | United States | $0.245B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.230B | 0.00 |
Omeros (OMER) | United States | $0.218B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.182B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.173B | 0.00 |
High Tide (HITI) | Canada | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
Fonar (FONR) | United States | $0.137B | 11.80 |
InterCure (INCR) | Israel | $0.116B | 19.61 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.110B | 0.00 |
FitLife Brands (FTLF) | United States | $0.107B | 20.86 |
Safety Shot (SHOT) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.083B | 45.50 |
Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.27 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.045B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.035B | 13.52 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |